205 related articles for article (PubMed ID: 25300908)
1. Mouse models of primary central nervous system lymphomas: tools for basing funding and therapeutic strategies.
Ben Abdelwahed Bagga R; Donnou S; Cosette J; Sautès-Fridman C; Aouni M; Fisson S
J Neurooncol; 2015 Jan; 121(1):9-18. PubMed ID: 25300908
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of primary central nervous system and primary intraocular lymphomas.
Tuaillon N; Chan CC
Curr Mol Med; 2001 May; 1(2):259-72. PubMed ID: 11899075
[TBL] [Abstract][Full Text] [Related]
3. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes.
Lim T; Kim SJ; Kim K; Lee JI; Lim DH; Lee DJ; Baek KK; Lee HY; Han B; Uhm JE; Ko YH; Kim WS
Ann Hematol; 2011 Dec; 90(12):1391-8. PubMed ID: 21479535
[TBL] [Abstract][Full Text] [Related]
4. Primary central nervous system lymphoma.
Ferreri AJ; Reni M
Crit Rev Oncol Hematol; 2007 Sep; 63(3):257-68. PubMed ID: 17590348
[TBL] [Abstract][Full Text] [Related]
5. Primary CNS lymphoma.
Touitou V; LeHoang P; Bodaghi B
Curr Opin Ophthalmol; 2015 Nov; 26(6):526-33. PubMed ID: 26367092
[TBL] [Abstract][Full Text] [Related]
6. Emerging insights into origin and pathobiology of primary central nervous system lymphoma.
You H; Wei L; Kaminska B
Cancer Lett; 2021 Jul; 509():121-129. PubMed ID: 33766752
[TBL] [Abstract][Full Text] [Related]
7. Primary CNS lymphoma patient-derived orthotopic xenograft model capture the biological and molecular characteristics of the disease.
Pouzoulet F; Alentorn A; Royer-Perron L; Assayag F; Mokhtari K; Labiod D; Le Garff-Tavernier M; Daniau M; Menet E; Peyre M; Schnitzler A; Guegan J; Davi F; Hoang-Xuan K; Soussain C
Blood Cells Mol Dis; 2019 Mar; 75():1-10. PubMed ID: 30502564
[TBL] [Abstract][Full Text] [Related]
8. Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma.
Ponzoni M; Issa S; Batchelor TT; Rubenstein JL
Ann Oncol; 2014 Feb; 25(2):316-22. PubMed ID: 24265352
[TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system lymphoma.
Grant JW; Isaacson PG
Brain Pathol; 1992 Apr; 2(2):97-109. PubMed ID: 1341961
[TBL] [Abstract][Full Text] [Related]
10. Treatment approaches for primary CNS lymphomas.
Carrabba MG; Reni M; Foppoli M; Chiara A; Franzin A; Politi LS; Villa E; Ciceri F; Ferreri AJ
Expert Opin Pharmacother; 2010 Jun; 11(8):1263-76. PubMed ID: 20429667
[TBL] [Abstract][Full Text] [Related]
11. Unusual variants of primary central nervous system lymphoma.
Shenkier TN
Hematol Oncol Clin North Am; 2005 Aug; 19(4):651-64, vi. PubMed ID: 16083828
[TBL] [Abstract][Full Text] [Related]
12. Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice.
Mulazzani M; Fräßle SP; von Mücke-Heim I; Langer S; Zhou X; Ishikawa-Ankerhold H; Leube J; Zhang W; Dötsch S; Svec M; Rudelius M; Dreyling M; von Bergwelt-Baildon M; Straube A; Buchholz VR; Busch DH; von Baumgarten L
Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24275-24284. PubMed ID: 31712432
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
[TBL] [Abstract][Full Text] [Related]
14. Low-grade primary central nervous system lymphoma in immunocompetent patients.
Jahnke K; Thiel E; Schilling A; Herrlinger U; Weller M; Coupland SE; Krümpelmann U; Stein H; Korfel A
Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082
[TBL] [Abstract][Full Text] [Related]
15. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
16. How I treat primary CNS lymphoma.
Ferreri AJ
Blood; 2011 Jul; 118(3):510-22. PubMed ID: 21613254
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in primary central nervous system lymphomas.
Ferreri AJ; Reni M
Hematol Oncol Clin North Am; 2005 Aug; 19(4):629-49, vi. PubMed ID: 16083827
[TBL] [Abstract][Full Text] [Related]
18. Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.
Ferreri AJ; Abrey LE; Blay JY; Borisch B; Hochman J; Neuwelt EA; Yahalom J; Zucca E; Cavalli F; Armitage J; Batchelor T
J Clin Oncol; 2003 Jun; 21(12):2407-14. PubMed ID: 12805341
[TBL] [Abstract][Full Text] [Related]
19. Primary central nervous system lymphoma and subcutaneous metastases.
Al Bahrani B; Henderson C; Delaney G
J Neurooncol; 2000 Apr; 47(2):141-4. PubMed ID: 10982155
[TBL] [Abstract][Full Text] [Related]
20. Primary central nervous system lymphoma: a review.
McAllister LD
Curr Neurol Neurosci Rep; 2002 May; 2(3):210-5. PubMed ID: 11936999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
